Post 9gs80eRlkH8dacsbUu by shanehawkk@noagendasocial.com
 (DIR) More posts by shanehawkk@noagendasocial.com
 (DIR) Post #9gryJqzqJN60TKKq0m by shanehawkk@noagendasocial.com
       2019-03-17T17:56:19Z
       
       0 likes, 1 repeats
       
       “Technically, there will never be generic insulin because it’s biologically based rather than chemical. Instead, there are bio-similars, which are products that are equivalent in function but they’re not 100 percent identical to the insulin they are replicating because the biological matter is very complex. Copying an existing chemical drug is straightforward. But for bio-similars, it is very difficult to point to a generic copy on insulin and prove that it is the same.”https://fee.org/articles/why-we-don-t-have-generic-insulin/
       
 (DIR) Post #9gs0nYnyi8AGeG4vc8 by Viking@noagendasocial.com
       2019-03-17T18:24:05Z
       
       0 likes, 0 repeats
       
       @shanehawkk The article points out that generics are often difficult to get through FDA certification, because of problems proving dose equivalency. That is correct, but really ridiculous, given that in most cases, doctors' dosing of a given drug is a try and fail and make corrections process. IE, for people with endocrine conditions, you try a best guess dose for a while, then do a blood test to see if any adjustment is needed.
       
 (DIR) Post #9gs2kqPWzqrUI6TaXw by shanehawkk@noagendasocial.com
       2019-03-17T18:46:01Z
       
       0 likes, 0 repeats
       
       @Viking I don’t understand your reply entirely. Are you saying the author’s point is ridiculous or the FDA’s review process is ridiculous for the dosing routine you described?
       
 (DIR) Post #9gs55CDxnvXfdztj5U by PhoneBoy@noagendasocial.com
       2019-03-17T19:12:06Z
       
       0 likes, 0 repeats
       
       @shanehawkk of course no one considers that maybe if people wouldn't eat so many carbs, they wouldn't need so much insulin. 🤔
       
 (DIR) Post #9gs5oY7pDvTObGeWvI by Viking@noagendasocial.com
       2019-03-17T19:20:18Z
       
       0 likes, 0 repeats
       
       @shanehawkk What I am saying is: often, determining the dose is more like cooking than science. Since you try and adjust anyway, it wouldn't be a big deal if the generic is 20% stronger or 20% weaker than the brand name it replaces, but dialing in the dose accuracy seems to be the limiting factor. There is a similar problem with asthma drug generics, in this case, the molecule is identical, but the delivery system results in a certain percentage reaching the bronchial tubes, where it matters.
       
 (DIR) Post #9gs80eRlkH8dacsbUu by shanehawkk@noagendasocial.com
       2019-03-17T19:44:54Z
       
       0 likes, 0 repeats
       
       @PhoneBoy My friend with type 1 is keto and still needs to pay a hefty price annually to live
       
 (DIR) Post #9gs88GvB657IwWGkro by shanehawkk@noagendasocial.com
       2019-03-17T19:46:16Z
       
       0 likes, 0 repeats
       
       @Viking I gotcha. So essentially the FDA’s longwinded process is unnecessary if doctors use an estimated dosing process and there’s no real reason for a standardized “unit” for insulin to go by